Deutsche Bank AG raised its position in Fabrinet (NYSE:FN - Free Report) by 35.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,277 shares of the technology company's stock after acquiring an additional 11,873 shares during the quarter. Deutsche Bank AG owned 0.12% of Fabrinet worth $9,956,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the company. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new position in shares of Fabrinet during the 4th quarter valued at approximately $3,915,000. Cetera Investment Advisers boosted its stake in shares of Fabrinet by 10.7% during the 4th quarter. Cetera Investment Advisers now owns 11,844 shares of the technology company's stock valued at $2,604,000 after buying an additional 1,146 shares during the last quarter. Captrust Financial Advisors boosted its stake in shares of Fabrinet by 77.2% during the 4th quarter. Captrust Financial Advisors now owns 1,878 shares of the technology company's stock valued at $413,000 after buying an additional 818 shares during the last quarter. Benjamin Edwards Inc. boosted its stake in shares of Fabrinet by 8.7% during the 4th quarter. Benjamin Edwards Inc. now owns 2,887 shares of the technology company's stock valued at $635,000 after buying an additional 231 shares during the last quarter. Finally, Algert Global LLC boosted its stake in shares of Fabrinet by 92.9% during the 4th quarter. Algert Global LLC now owns 55,296 shares of the technology company's stock valued at $12,158,000 after buying an additional 26,633 shares during the last quarter. Institutional investors and hedge funds own 97.38% of the company's stock.
Wall Street Analysts Forecast Growth
FN has been the subject of several research analyst reports. JPMorgan Chase & Co. increased their target price on Fabrinet from $220.00 to $235.00 and gave the company a "neutral" rating in a research note on Tuesday, May 6th. Rosenblatt Securities raised their price objective on Fabrinet from $230.00 to $250.00 and gave the stock a "buy" rating in a research note on Tuesday, May 6th. B. Riley upgraded Fabrinet from a "sell" rating to a "neutral" rating and reduced their price objective for the stock from $178.00 to $176.00 in a research note on Friday, April 4th. Needham & Company LLC restated a "buy" rating and set a $280.00 price objective on shares of Fabrinet in a research note on Tuesday, May 6th. Finally, Fox Advisors started coverage on Fabrinet in a research note on Tuesday, February 18th. They set an "overweight" rating and a $270.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $239.29.
View Our Latest Stock Analysis on Fabrinet
Fabrinet Stock Down 0.0%
FN stock traded down $0.05 during mid-day trading on Tuesday, reaching $227.72. The company had a trading volume of 545,265 shares, compared to its average volume of 625,493. The stock has a market capitalization of $8.16 billion, a P/E ratio of 25.47 and a beta of 0.95. Fabrinet has a one year low of $148.55 and a one year high of $281.79. The stock's 50-day simple moving average is $203.54 and its two-hundred day simple moving average is $218.84.
Fabrinet (NYSE:FN - Get Free Report) last posted its earnings results on Monday, May 5th. The technology company reported $2.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.47 by $0.05. The company had revenue of $871.80 million for the quarter, compared to analysts' expectations of $857.12 million. Fabrinet had a return on equity of 18.48% and a net margin of 10.44%. The firm's quarterly revenue was up 19.2% compared to the same quarter last year. During the same period last year, the business posted $2.39 earnings per share. On average, research analysts forecast that Fabrinet will post 9.4 EPS for the current fiscal year.
Insider Buying and Selling at Fabrinet
In other news, Director Rollance E. Olson sold 2,500 shares of the firm's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $223.98, for a total transaction of $559,950.00. Following the transaction, the director now directly owns 23,201 shares of the company's stock, valued at approximately $5,196,559.98. This trade represents a 9.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.38% of the stock is currently owned by company insiders.
Fabrinet Profile
(
Free Report)
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing.
Featured Articles

Before you consider Fabrinet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fabrinet wasn't on the list.
While Fabrinet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.